Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Debt / NOTE 8.000% 7/1
-
Number of holders
-
3
-
Total 13F principal, excl. options
-
33,574,000
-
Principal change
-
+33,574,000
-
Total reported value, excl. options
-
$63,951,074
-
Value change
-
+$63,951,074
-
Number of buys
-
3
-
Price
-
$1.90
Significant Holders of XERIS BIOPHARMA HOLDINGS INC - NOTE 8.000% 7/1 as of Q1 2025
3 filings reported holding 98422EAB9 - XERIS BIOPHARMA HOLDINGS INC - NOTE 8.000% 7/1 as of Q1 2025.
XERIS BIOPHARMA HOLDINGS INC - NOTE 8.000% 7/1 has 3 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $33,574,000 of principal
.
Largest 3 bondholders include CAPSTONE INVESTMENT ADVISORS, LLC ($20,900,000 of principal), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ($10,500,000 of principal), and Sessa Capital IM, L.P. ($2,174,000 of principal).
This table shows the top 3 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.